Blueprint Medicines Corporation Share Price
Equities
BPMC
US09627Y1091
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93 USD | +2.50% | +7.08% | +0.82% |
04-25 | Transcript : Blueprint Medicines Corporation - Special Call | |
03-22 | Blueprint Medicines Insider Sold Shares Worth $2,188,265, According to a Recent SEC Filing | MT |
Sales 2024 * | 393M 31.46B | Sales 2025 * | 599M 47.98B | Capitalization | 5.84B 468B |
---|---|---|---|---|---|
Net income 2024 * | -340M -27.22B | Net income 2025 * | -161M -12.89B | EV / Sales 2024 * | 14.5 x |
Net cash position 2024 * | 129M 10.31B | Net cash position 2025 * | 38.3M 3.07B | EV / Sales 2025 * | 9.68 x |
P/E ratio 2024 * |
-16.8
x | P/E ratio 2025 * |
-36.1
x | Employees | 655 |
Yield 2024 * |
-
| Yield 2025 * |
1.08% | Free-Float | 99.18% |
Latest transcript on Blueprint Medicines Corporation
1 day | +2.50% | ||
1 week | +7.08% | ||
Current month | -1.96% | ||
1 month | +3.71% | ||
3 months | +14.03% | ||
6 months | +68.42% | ||
Current year | +0.82% |
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 04/01/16 |
Alexis Borisy
FOU | Founder | 52 | 30/09/08 |
Director of Finance/CFO | 52 | 31/08/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 13/04/16 |
Alexis Borisy
FOU | Founder | 52 | 30/09/08 |
Lonnel Coats
BRD | Director/Board Member | 58 | 03/02/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 0 M€ | 0.00% | - | |
0.24% | 0 M€ | 0.00% | - | |
0.18% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 93 | +2.50% | 725,963 |
25/04/24 | 90.73 | -1.66% | 755,177 |
24/04/24 | 92.26 | -0.03% | 588,540 |
23/04/24 | 92.29 | +1.85% | 788,709 |
22/04/24 | 90.61 | +4.33% | 792,073 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.82% | 5.84B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BPMC Stock